Processing, please wait...

Dr Nataliia PETRYK


2010 MD Shupyk National Medical Academy of Postgraduate Education, Kyiv Residency Obstetrics and gynecology
2006 MD Kharkiv National Medical University Ukraine, Kharkiv, Kharkivska oblast

2019 Certificate of Merit "Topgun Amongst the Surgeon in the Objective Skills Clinical Examination"
2006 Graduated from Kharkiv National Medical Univesity with Honor

June 2019 Diploma in Minimal Access Surgery
World Association of Laparoscopic Surgeons, India
June 2019 Fellowship in Minimal Access Surgery World Association of Laparoscopic Surgeons, India
November 2017 Laporoscopy on Human Body Donors Kiel School of Gynaecological Endoscopy, Germany
June 2017 Advanced Training Course Kiel School of Gynaecological Endoscopy, Germany
April 2017 Standart Training Course Kiel School of Gynaecological Endoscopy, Germany
April 2012 Specialization in the Organization of Management in the Health Care
System. Shupyk National Medical Academy of Postgraduate Education, Ukraine
December 2011 Ultrasonography Shupyk National Medical Academy of Postgraduate Education, Ukraine
November 2011 Reproductive endocrinology Shupyk National Medical Academy of Postgraduate Education, Ukraine

June 2010 Gynecology
November 2019 Plastic Surgery

November 2019 General Surgery


Jun 2010 Private Practice, Ultrasound Pro Medical Centre
May 2010 To May 2012 Hospital Employee, Maternity Hospital Reproductive and Perinatal Medical Center Urgent Care Doctor for Women


September 2017 Pathogenetic Justification for the Use of Mesenchymal Stem Cells PhD program in Kharkiv National Medical University
May 2015 Ovarian Rejuvenation Therapy Treatment for women with early menopause and low ovarian reserve without hormone replacement therapy


Russian Fluent
Ukrainian Fluent
English Fluent

read more
add item add Nataliia PETRYK

Nataliia PETRYK's publications (2)

Anti-inflammatory Activity of Mesenchymal Stem Cells in λ-Carrageenan-Induced Chronic Inflammation in Rats: Reactions of the Blood System, Leukocyte-Monocyte Ratio.

Oct, 2020

The variety of chronic diseases caused by a chronic inflammatory process is an unresolved problem in developed countries. Due to this, modern medicine lacks effective, pathogenetic mechanisms of treatment or at least improvement of the quality of life of people with so-called diseases of civilization. The purpose of this study was to investigate the anti-inflammatory and immunomodulatory ability of mesenchymal stem cells (MSCs) in a model of λ-carrageenan secondary chronic inflammation in rats. MSCs derived from rat femoral epiphysis were used. At the current level of medicine, many highly specific markers of chronic inflammation are available that will also be studied later (α-TNF, IL 6, C-reactive protein); however, this article will consider the study of the most accessible but at the same time very informative indicators of the inflammatory process-a common total blood count-leukocytes, leukocyte formula, and LMR. The study was performed on 132 male Wistar rats weighing 180-200 g, which were divided into 12 groups. The inflammation was caused by the introduction of 10 mg λ-carrageenan intramuscular in right hip. After induction of edema, the experimental groups of rats were administered MSCs into the inflamed site, in the amount of 1-2 million cells once. Blood sampling was performed from 6 h to 28 days. With one-way ANOVA followed by Tukey-Kramer multiple comparisons test, p < 0.05, we compared our groups of animals. In the detailed dynamics of inflammation, from the 6th hour to the 28th day (ten terms), the reactions of the blood system and their mechanisms were investigated. There were intact rats-6 animals without any interventions, as well as rats administered MSCs without causing inflammation (6 animals) in experiment. In this experiment, the lymphocyte-monocyte ratio in rats is described for the first time, demonstrating the suppression of chronic inflammation by means of MSCs. read more


Mesenchymal Stem Cells Anti-Inflammatory Activity in Rats: Proinflammatory Cytokines.


Many widespread intractable diseases are caused or supported by chronic inflammation. Such conditions include the 2nd type of diabetes mellitus, atherosclerosis, neurodegenerative diseases, chronic inflammatory diseases of the connective tissue - ankylosing spondylitis, rheumatoid arthritis, autoimmune myositis, etc. Therefore, the search for targeted treatment of these illnesses is extremely in high demand. Immunomodulatory activity of mesenchymal stem cells is one of their remarkable properties. Several biomarkers (cytokines and nonspecific proteins) are known to be associated with chronic inflammation. read more

Journal of inflammation research

Nataliia PETRYK's scientific societies (1)